Robert A. Blake

6.8k total citations · 1 hit paper
32 papers, 2.4k citations indexed

About

Robert A. Blake is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert A. Blake has authored 32 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Robert A. Blake's work include Protein Degradation and Inhibitors (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Robert A. Blake is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Robert A. Blake collaborates with scholars based in United States, United Kingdom and Norway. Robert A. Blake's co-authors include Li Sun, Sara A. Courtneidge, Martin A. Broome, Jianming Wu, Mikhail L. Gishizky, Xiangdong Liu, Julie M. Cherrington, Steve P. Watson, Alexander Laird and Emily Chan and has published in prestigious journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Robert A. Blake

32 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling

2000 520 citations Robert A. Blake, Martin A. Broome et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Blake United States	16	1.6k	633	323	259	247	32	2.4k
Marina Holgado-Madruga United States	24	2.4k 1.5×	1.1k 1.7×	427 1.3×	378 1.5×	94 0.4×	33	3.3k
Frauke Bataille Germany	28	1.4k 0.9×	770 1.2×	278 0.9×	389 1.5×	58 0.2×	41	2.6k
Ai-Min Hui United States	15	1.4k 0.9×	558 0.9×	311 1.0×	324 1.3×	532 2.2×	16	2.2k
Radha P. Narsimhan United States	16	1.9k 1.2×	646 1.0×	1.6k 4.9×	305 1.2×	155 0.6×	20	3.1k
Paola Longati Italy	25	1.8k 1.2×	680 1.1×	1.4k 4.4×	229 0.9×	107 0.4×	31	3.1k
Chouhei Sakakura Japan	27	1.2k 0.8×	723 1.1×	112 0.3×	337 1.3×	68 0.3×	104	2.4k
Jiří Ehrmann Czechia	24	1.3k 0.9×	777 1.2×	94 0.3×	655 2.5×	55 0.2×	113	2.6k
Serk In Park United States	27	1.2k 0.8×	1.1k 1.8×	69 0.2×	472 1.8×	136 0.6×	57	2.3k
Yoshinobu Toda Japan	26	1.2k 0.7×	496 0.8×	182 0.6×	440 1.7×	33 0.1×	50	2.0k
Masaharu Sakamoto Japan	20	810 0.5×	474 0.7×	559 1.7×	262 1.0×	44 0.2×	58	2.0k

Countries citing papers authored by Robert A. Blake

Since Specialization

Citations

This map shows the geographic impact of Robert A. Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Blake more than expected).

Fields of papers citing papers by Robert A. Blake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Blake. The network helps show where Robert A. Blake may publish in the future.

Co-authorship network of co-authors of Robert A. Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Blake. A scholar is included among the top collaborators of Robert A. Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Blake. Robert A. Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yuebiao, Elisia Villemure, Huy Nguyen, et al.. (2024). Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery. ACS Medicinal Chemistry Letters. 15(12). 2158–2163. 3 indexed citations

Cho, Kelvin F., P. Taylur, Christopher M. Rose, et al.. (2020). Chaperone mediated detection of small molecule target binding in cells. Nature Communications. 11(1). 465–465. 10 indexed citations

Metcalfe, Ciara, Wei Zhou, Jane Guan, et al.. (2020). Abstract 3406: GDC-9545: A pure antiestrogen clinical candidate that immobilizes the estrogen receptor and profoundly alters chromatin accessibility in vivo. Cancer Research. 80(16_Supplement). 3406–3406. 4 indexed citations

Blake, Robert A.. (2019). Abstract 4452: GNE-0011, a novel monovalent BRD4 degrader. 4452–4452. 5 indexed citations

Guan, Jane, Wei Zhou, Anneleen Daemen, et al.. (2018). Abstract NG05: Not all “SERDs” are equal: Context-independent ER degradation and full ER antagonism define the next generation of ER therapeutics. Cancer Research. 78(13_Supplement). NG05–NG05. 1 indexed citations

Lello, Paola Di, Richard Pastor, Jeremy Murray, et al.. (2017). Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques. Journal of Medicinal Chemistry. 60(24). 10056–10070. 65 indexed citations

Hartman, Steven J., Tracy Kleinheinz, Jonathan White, et al.. (2017). Abstract 3621: Characterization of the effects of estrogen receptor alpha Y537S and D538G mutations on receptor pharmacology. Cancer Research. 77(13_Supplement). 3621–3621. 1 indexed citations

Lau, Ted, Emily Chan, Marinella Callow, et al.. (2013). A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth. Cancer Research. 73(10). 3132–3144. 256 indexed citations

Lyman, Susan K., Suzanne Crawley, Ruoyu Gong, et al.. (2011). High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888. PLoS ONE. 6(3). e17692–e17692. 24 indexed citations

10.

Blake, Robert A.. (2006). Target Validation in Drug Discovery. Humana Press eBooks. 356. 367–378. 14 indexed citations

11.

Laird, Alexander, et al.. (2004). Design and Synthesis of Aminopropyl Tetrahydroindole‐Based Indolin‐2‐ones as Selective and Potent Inhibitors of Src and Yes Tyrosine Kinase.. ChemInform. 35(18). 1 indexed citations

12.

Bhawe, Kaumudi, Robert A. Blake, Douglas O. Clary, & Peter M. Flanagan. (2004). An Automated Image Capture and Quantitation Approach to Identify Proteins Affecting Tumor Cell Proliferation. SLAS DISCOVERY. 9(3). 216–222. 11 indexed citations

13.

Wang, Xueyan, Phuong Le, Congxin Liang, et al.. (2003). Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.. PubMed. 2(11). 1085–92. 93 indexed citations

14.

Moshinsky, Deborah, Lany Ruslim, Robert A. Blake, & Flora Tang. (2003). A Widely Applicable, High-Throughput TR-FRET Assay for the Measurement of Kinase Autophosphorylation: VEGFR-2 as a Prototype. SLAS DISCOVERY. 8(4). 447–452. 25 indexed citations

15.

Laird, Alexander, et al.. (2003). Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 14(1). 187–190. 45 indexed citations

16.

Christensen, James G., Randall Schreck, Jon Burrows, et al.. (2003). A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.. PubMed. 63(21). 7345–55. 421 indexed citations

17.

Blake, Robert A., Martin A. Broome, Xiangdong Liu, et al.. (2000). SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling. Molecular and Cellular Biology. 20(23). 9018–9027. 520 indexed citations breakdown →

18.

Blake, Robert A., Judith Asselin, Trevor R. Walker, & Steve P. Watson. (1994). Fcγ receptor II stimulated formation of inositol phosphates in human platelets is blocked by tyrosine kinase inhibitors and associated with tyrosine phosphorylation of the receptor. FEBS Letters. 342(1). 15–18. 24 indexed citations

19.

Blake, Robert A., Gary L. Schieven, & Steve P. Watson. (1994). Collagen stimulates tyrosine phosphorylation of phospholipase C‐γ2 but not phospholipase C‐γ1 in human platelets. FEBS Letters. 353(2). 212–216. 115 indexed citations

20.

Blake, Robert A. & Jan P. Allebach. (1981). Digital ultrasonic image construction using electronic ordered dither techniques. Journal of Nondestructive Evaluation. 2(1). 75–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact